TO: Health News Reporters/Producers; Analysts
WHAT: Merck & Co., Inc. will host a briefing for reporters and
analysts following the close of the U.S. Food and Drug
Administration's (FDA) Arthritis Advisory Committee Meeting
on ARCOXIA (etoricoxib) to discuss the outcome of the meeting
and to participate in a question and answer session.
